Last reviewed · How we verify
Budesonide, Formoterol Fumarate Dihydrate
Budesonide, Formoterol Fumarate Dihydrate is a Small molecule drug developed by Teva Pharma GmbH. It is currently FDA-approved. Also known as: DuoResp® Spiromax®.
At a glance
| Generic name | Budesonide, Formoterol Fumarate Dihydrate |
|---|---|
| Also known as | DuoResp® Spiromax® |
| Sponsor | Teva Pharma GmbH |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Anti-Inflammatory Reliever South Africa (PHASE3)
- Expertise Asthma COPD Program with Digital Support (PHASE3)
- BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient (PHASE3)
- Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients (PHASE3)
- A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers (PHASE1)
- Clinical Study to Evaluate Z7200 Pharmacokinetics Profile (PHASE1)
- Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients (PHASE2)
- Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Budesonide, Formoterol Fumarate Dihydrate CI brief — competitive landscape report
- Budesonide, Formoterol Fumarate Dihydrate updates RSS · CI watch RSS
- Teva Pharma GmbH portfolio CI
Frequently asked questions about Budesonide, Formoterol Fumarate Dihydrate
What is Budesonide, Formoterol Fumarate Dihydrate?
Budesonide, Formoterol Fumarate Dihydrate is a Small molecule drug developed by Teva Pharma GmbH.
Who makes Budesonide, Formoterol Fumarate Dihydrate?
Budesonide, Formoterol Fumarate Dihydrate is developed and marketed by Teva Pharma GmbH (see full Teva Pharma GmbH pipeline at /company/teva-pharma-gmbh).
Is Budesonide, Formoterol Fumarate Dihydrate also known as anything else?
Budesonide, Formoterol Fumarate Dihydrate is also known as DuoResp® Spiromax®.
What development phase is Budesonide, Formoterol Fumarate Dihydrate in?
Budesonide, Formoterol Fumarate Dihydrate is FDA-approved (marketed).
Related
- Manufacturer: Teva Pharma GmbH — full pipeline
- Also known as: DuoResp® Spiromax®
- Compare: Budesonide, Formoterol Fumarate Dihydrate vs similar drugs
- Pricing: Budesonide, Formoterol Fumarate Dihydrate cost, discount & access